Learn More
ÿþýüûúùüü ÿ In this contribution two solutions for the management of cellular intranet, based on the Mobile IP and Cellular IP protocols integration are investigated. The first solution adopts a centralized architecture build over the gateway and the home agent. It is most suited for security needs and client/server traffic. The second solution utilizes the(More)
OBJECTIVES The purpose of this study was to investigate the effect of the RenalGuard System (PLC Medical Systems, Milford, Massachusetts) on prevention of acute kidney injury (AKI) in patients undergoing transcatheter aortic valve replacement (TAVR). BACKGROUND TAVR is associated with varying degrees of post-procedural AKI. The RenalGuard System is a(More)
94 strains of Pseudomonas aeruginosa, isolated from hospitalized patients, were typed with serological and pyocinic methods, also testing their sensitivity to 6 antibiotics. The serological method allowed for the typing of almost all the strains (98.9%), (the 0-11 serotype was the most frequent -23.4%-) vs. 80.6% by the pyocinic method. Among those tested,(More)
OBJECTIVE The aim of this study was to conduct a weighted meta-analysis to determine the rates of acute (≤30days) major outcomes after (TAVR) with second-generation devices. METHODS A comprehensive search of multiple electronic databases from January 2011 to May 2017 was conducted using predefined criteria. New-generation TAVR devices were defined as any(More)
BACKGROUND We sought to describe an optimized approach to coronary artery disease (CAD) screening and management in patients undergoing transcatheter aortic valve replacement (TAVR). METHODS AND RESULTS When invasive coronary angiography showed CAD, the treatment strategy and completeness of revascularization was determined based on coronary anatomy. TAVR(More)
In a planned prospective study 39 consecutive patients with stage III ovarian cancer have been admitted in two years. All patients have received initial extensive surgery followed on as out patients basis by 5 courses of A-Cy chemotherapy and by a second operation and further non cross resistant chemotherapy with Platinum, Hexamethyl-Melamine,(More)
  • 1